BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 17323194)

  • 1. Mitemcinal (GM-611), an orally active motilin receptor agonist, accelerates colonic motility and bowel movement in conscious dogs.
    Ozaki K; Sudo H; Muramatsu H; Yogo K; Kamei K; Koga H; Itoh Z; Omura S; Takanashi H
    Inflammopharmacology; 2007 Feb; 15(1):36-42. PubMed ID: 17323194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of mitemcinal (GM-611), an acid-resistant nonpeptide motilin receptor agonist, on the gastrointestinal contractile activity in conscious dogs.
    Ozaki K; Yogo K; Sudo H; Onoma M; Kamei K; Akima M; Koga H; Itoh Z; Omura S; Takanashi H
    Pharmacology; 2007; 79(4):223-35. PubMed ID: 17426410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral mitemcinal (GM-611), an erythromycin-derived prokinetic, accelerates normal and experimentally delayed gastric emptying in conscious dogs.
    Onoma M; Yogo K; Ozaki K; Kamei K; Akima M; Koga H; Itoh Z; Omura S; Takanashi H
    Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):35-42. PubMed ID: 18047625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulatory action of mitemcinal (GM-611), an acid-resistant non-peptide motilin receptor agonist, on colonic motor activity and defecation: spontaneous and mitemcinal-induced giant migrating contractions during defecation in dogs.
    Hirabayashi T; Morikawa Y; Matsufuji H; Hoshino K; Hagane K; Ozaki K
    Neurogastroenterol Motil; 2009 Oct; 21(10):1085-e91. PubMed ID: 19508333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An orally active motilin receptor antagonist, MA-2029, inhibits motilin-induced gastrointestinal motility, increase in fundic tone, and diarrhea in conscious dogs without affecting gastric emptying.
    Ozaki K; Onoma M; Muramatsu H; Sudo H; Yoshida S; Shiokawa R; Yogo K; Kamei K; Cynshi O; Kuromaru O; Peeters TL; Takanashi H
    Eur J Pharmacol; 2009 Aug; 615(1-3):185-92. PubMed ID: 19445919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitemcinal (GM-611), an orally active motilin agonist, facilitates defecation in rabbits and dogs without causing loose stools.
    Sudo H; Ozaki K; Muramatsu H; Kamei K; Yogo K; Cynshi O; Koga H; Itoh Z; Omura S; Takanashi H
    Neurogastroenterol Motil; 2007 Apr; 19(4):318-26. PubMed ID: 17391248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro pharmacological characterization of mitemcinal (GM-611), the first acid-resistant non-peptide motilin receptor agonist, in smooth muscle of rabbit small intestine.
    Takanashi H; Yogo K; Ozaki K; Koga H; Itoh Z; Omura S
    Pharmacology; 2007; 79(3):137-48. PubMed ID: 17183187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitemcinal (GM-611), an orally active motilin receptor agonist, improves delayed gastric emptying in a canine model of diabetic gastroparesis.
    Onoma M; Ozaki K; Yogo K; Monnai M; Muramatsu H; Kamei K; Kawabe Y; Hayashi S; Shiga T; Matsuo S; Suzuki M; Itoh Z; Omura S; Takanashi H
    Clin Exp Pharmacol Physiol; 2008 Jul; 35(7):788-96. PubMed ID: 18346169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GSK962040: a small molecule, selective motilin receptor agonist, effective as a stimulant of human and rabbit gastrointestinal motility.
    Sanger GJ; Westaway SM; Barnes AA; Macpherson DT; Muir AI; Jarvie EM; Bolton VN; Cellek S; Näslund E; Hellström PM; Borman RA; Unsworth WP; Matthews KL; Lee K
    Neurogastroenterol Motil; 2009 Jun; 21(6):657-64, e30-1. PubMed ID: 19374732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral administration of MA-2029, a novel selective and competitive motilin receptor antagonist, inhibits motilin-induced intestinal contractions and visceral pain in rabbits.
    Sudo H; Yoshida S; Ozaki K; Muramatsu H; Onoma M; Yogo K; Kamei K; Cynshi O; Kuromaru O; Peeters TL; Takanashi H
    Eur J Pharmacol; 2008 Mar; 581(3):296-305. PubMed ID: 18164286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Motilide, motilin-like macrolides].
    Omura S; Inatomi N; Itoh Z
    Tanpakushitsu Kakusan Koso; 1993 Aug; 38(11):1881-90. PubMed ID: 8210432
    [No Abstract]   [Full Text] [Related]  

  • 12. An erythromycin derivative, EM-523, induces motilin-like gastrointestinal motility in dogs.
    Inatomi N; Satoh H; Maki Y; Hashimoto N; Itoh Z; Omura S
    J Pharmacol Exp Ther; 1989 Nov; 251(2):707-12. PubMed ID: 2810120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of motilin and mitemcinal (GM-611) on gastrointestinal contractile activity in rhesus monkeys in vivo and in vitro.
    Yogo K; Ozaki K; Takanashi H; Koto M; Itoh Z; Omura S
    Dig Dis Sci; 2007 Nov; 52(11):3112-22. PubMed ID: 17431782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythromycin: a motilin agonist and gastrointestinal prokinetic agent.
    Weber FH; Richards RD; McCallum RW
    Am J Gastroenterol; 1993 Apr; 88(4):485-90. PubMed ID: 8470625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of motilin receptors on rabbit colon myocytes by chronic oral erythromycin.
    Bologna SD; Hasler WL; Owyang C
    J Pharmacol Exp Ther; 1993 Aug; 266(2):852-6. PubMed ID: 8355213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GM-611 (Chugai Pharmaceutical).
    Peeters TL
    Curr Opin Investig Drugs; 2001 Apr; 2(4):555-7. PubMed ID: 11566017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of TZP-201, a novel motilin receptor antagonist, in the colon of the musk shrew (Suncus murinus).
    Venkova K; Thomas H; Fraser GL; Greenwood-Van Meerveld B
    J Pharm Pharmacol; 2009 Mar; 61(3):367-73. PubMed ID: 19222910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EM574, an erythromycin derivative, is a potent motilin receptor agonist in human gastric antrum.
    Satoh M; Sakai T; Sano I; Fujikura K; Koyama H; Ohshima K; Itoh Z; Omura S
    J Pharmacol Exp Ther; 1994 Oct; 271(1):574-9. PubMed ID: 7965757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonlinear intestinal pharmacokinetics of mitemcinal, the first acid-resistant non-peptide motilin receptor agonist, in rats.
    Saitoh R; Miyayama T; Mitsui T; Akiba Y; Higashida A; Takata S; Kawanishi T; Aso Y; Itoh Z; Omura S
    Xenobiotica; 2007 Dec; 37(12):1421-32. PubMed ID: 17926229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mechanism and clinical application of erythromycin as a gastrointestinal prokinetic agent in children].
    Yang Y
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Feb; 10(1):102-4. PubMed ID: 18289489
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 23.